{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:29:12Z","timestamp":1776425352016,"version":"3.51.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374009"],"award-info":[{"award-number":["82374009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Swertiamarin, a predominant iridoid glycoside from hepatoprotective Swertia herbs, is biotransformed <jats:italic>in vivo<\/jats:italic> into nitrogen-containing metabolites (<jats:italic>R<\/jats:italic>)-gentiandiol and (<jats:italic>S<\/jats:italic>)-gentiandiol. These metabolites may be the real active hepatoprotective agents. A high-fat diet-fed rat model was treated for 12 weeks with swertiamarin, (<jats:italic>R<\/jats:italic>)-gentiandiol, (<jats:italic>S<\/jats:italic>)-gentiandiol and silybin, and the therapeutic effects on non-alcoholic fatty liver disease (NAFLD) were systematically evaluated through biochemical indices and histopathological observations. Swertiamarin and (<jats:italic>R<\/jats:italic>)-gentiandiol reversed high-fat diet-induced metabolic disturbances, reduced serum alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglyceride, low-density lipoprotein cholesterol and malondialdehyde, while elevated high-density lipoprotein cholesterol, superoxide dismutase and glutathione peroxidase. However, (<jats:italic>S<\/jats:italic>)-gentiandiol exhibited no efficacy. The differential biomarkers in the serum of high-fat diet-fed rats were determined and identified by the metabolomics method combined with multivariate analysis. The results of enrichment analysis showed that NAFLD could be improved by swertiamarin and (<jats:italic>R<\/jats:italic>)-gentiandiol by regulating the levels of 21 biomarkers, such as stearic acid, palmitic acid and PC (36:3). According to the pathway enrichment results, swertiamarin and (<jats:italic>R<\/jats:italic>)-gentiandiol had potent combined effects in regulating taurine and hypotaurine metabolism, arachidonic acid metabolism, etc. This study is the first verification of the metabolite activity in the NAFLD model, and the dose-dependent effects of (<jats:italic>R<\/jats:italic>)-gentiandiol can be used to underscore its central role in swertiamarin\u2019s bioactivity. These findings offer valuable insights to clarify the pharmaceutical material for hepatoprotective effect of <jats:italic>Swertia<\/jats:italic> herbs.<\/jats:p>","DOI":"10.3389\/fphar.2025.1655026","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T08:00:45Z","timestamp":1758528045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanism of swertiamarin and novel nitrogen-containing metabolites (R)-Gentiandiol and (S)-Gentiandiol in treating non-alcoholic fatty liver disease in rats: an untargeted metabolomics study based on UPLC-Q-TOF\/MS"],"prefix":"10.3389","volume":"16","author":[{"given":"Yidan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yige","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianna","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00726-015-1969-2","article-title":"Enhancement of cysteine catabolism into taurine impacts glutathione homeostasis in rats challenged with ethanol","volume":"47","author":"Ahn","year":"2015","journal-title":"Amino acids"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves\u2010Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/ptt.s342911","article-title":"Non-alcoholic fatty liver disease (NAFLD) in patients with psoriasis: a review of the hepatic effects of systemic therapies","volume":"11","author":"Balak","year":"2021","journal-title":"Psoriasis Targets Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e000032","DOI":"10.1161\/hcg.0000000000000032","article-title":"Potential impact and study considerations of metabolomics in cardiovascular health and disease: a scientific statement from the American heart association","volume":"10","author":"Cheng","year":"2017","journal-title":"Circ. Cardiovasc Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41467-018-08085-x","article-title":"Publisher correction: serotonin signals through a gut-liver axis to regulate hepatic steatosis","volume":"10","author":"Choi","year":"2019","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"584090","DOI":"10.3389\/fphar.2020.584090","article-title":"Da-chai-hu decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease through remodeling the gut microbiota and modulating the serum metabolism","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1039\/c8fo00168e","article-title":"Hepatoprotective activity of iridoids, seco-iridoids and analog glycosides from gentianaceae on HepG2 cells via CYP3A4 induction and mitochondrial pathway","volume":"9","author":"Dai","year":"2018","journal-title":"Food Funct."},{"key":"B8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41538-024-00329-z","article-title":"High-fiber basil seed flour reduces insulin resistance and hepatic steatosis in high-fat diet mice","volume":"8","author":"Far\u00edas","year":"2024","journal-title":"npj Sci. Food"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/aps.2016.165","article-title":"A new method to evaluate the dose-effect relationship of a TCM formula Gegen Qinlian Decoction:\u201cFocus\u201d mode of integrated biomarkers","volume":"38","author":"Huang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2174\/1389201018666171026153515","article-title":"Swertia chirata: a comprehensive review with recent advances","volume":"18","author":"Jauhari","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/hypertensionaha.121.17824","article-title":"Macrophage 12 (S)-HETE enhances angiotensin II\u2013induced contraction by a BLT2 (Leukotriene B4 Type-2 Receptor) and TP (Thromboxane receptor)-mediated mechanism in murine arteries","volume":"79","author":"Kriska","year":"2022","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2170001","DOI":"10.1002\/mnfr.202170001","article-title":"Front cover: dietary fiber from oat and rye brans ameliorate western diet\u2013induced body weight gain and hepatic inflammation by the modulation of short\u2010chain fatty acids, bile acids, and tryptophan metabolism","volume":"65","author":"Kundi","year":"2021","journal-title":"Mol. Nutr. and food Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2024.2223","article-title":"Sodium-Glucose Cotransporter-2 inhibitor enhances hepatic gluconeogenesis and reduces lipid accumulation via AMPK-SIRT1 activation and autophagy induction","author":"Lee","year":"2025","journal-title":"Endocrinol. Metabolism"},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40360-020-00438-x","article-title":"Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease","volume":"21","author":"Lin","year":"2020","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1386207322666190411112814","article-title":"Effect of Chinese herbal monomer hairy calycosin on nonalcoholic fatty liver rats and its mechanism","volume":"22","author":"Liu","year":"2019","journal-title":"Comb. Chem. and High Throughput Screen."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e25358","DOI":"10.1097\/md.0000000000025358","article-title":"Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: a protocol for systematic review and meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.fct.2012.10.034","article-title":"Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats","volume":"52","author":"Mihailovi\u0107","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2131\/jts.45.87","article-title":"Taurine attenuates hepatic steatosis in a genetic model of fatty liver disease","volume":"45","author":"Miyata","year":"2020","journal-title":"J. Toxicol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00726-012-1381-0","article-title":"Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine","volume":"46","author":"Miyazaki","year":"2014","journal-title":"Amino acids"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J. gastroenterology WJG"},{"key":"B22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopha.2016.07.028","article-title":"Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis","volume":"83","author":"Patel","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1080\/13880209.2022.2127153","article-title":"Swertia mussotii prevents high-fat diet-induced non-alcoholic fatty liver disease in rats by inhibiting expression the TLR4\/MyD88 and the phosphorylation of NF-\u03baB","volume":"60","author":"Si","year":"2022","journal-title":"Pharm. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106482","DOI":"10.1016\/j.prostaglandins.2020.106482","article-title":"Regulation of arachidonic acid oxidation and metabolism by lipid electrophiles","volume":"152","author":"Trostchansky","year":"2021","journal-title":"Prostagl. and Other Lipid Mediat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-021-00565-8","article-title":"Natural history of NAFLD: knowns and unknowns","volume":"19","author":"Tsochatzis","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100104","DOI":"10.1016\/j.jlr.2021.100104","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","volume":"62","author":"Vvedenskaya","year":"2021","journal-title":"J. lipid Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/10286020.2011.631132","article-title":"Determination of novel nitrogen-containing metabolite after oral administration of swertiamarin to rats","volume":"14","author":"Wang","year":"2012","journal-title":"J. Asian Nat. Prod. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non\u2010alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1800536","DOI":"10.1002\/mnfr.201800536","article-title":"Taurine is involved in energy metabolism in muscles, adipose tissue, and the liver","volume":"63","author":"Wen","year":"2019","journal-title":"Mol. Nutr. and food Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1159\/000475639","article-title":"Antioxidant and hepatoprotective effect of swertiamarin on carbon tetrachloride-induced hepatotoxicity via the Nrf2\/HO-1 pathway","volume":"41","author":"Wu","year":"2017","journal-title":"Cell. Physiology Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/2225-4110.110411","article-title":"Recent advances in the herbal treatment of non-alcoholic Fatty liver disease","volume":"3","author":"Xiao","year":"2013","journal-title":"J. traditional complementary Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/21623945.2021.1906510","article-title":"Swertiamarin supplementation prevents obesity-related chronic inflammation and insulin resistance in mice fed a high-fat diet","volume":"10","author":"Xu","year":"2021","journal-title":"Adipocyte"},{"key":"B33","doi-asserted-by":"publisher","first-page":"152782","DOI":"10.1016\/j.phymed.2018.12.005","article-title":"Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice","volume":"59","author":"Yang","year":"2019","journal-title":"Phytomedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"112556","DOI":"10.1016\/j.jep.2020.112556","article-title":"Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response","volume":"255","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/etm.2015.2846","article-title":"Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-\u03b3 and insulin receptor in a rat model of nonalcoholic fatty liver disease","volume":"11","author":"Zhao","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"173976","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.21037\/atm-20-3594","article-title":"A narrative review of the roles of indoleamine 2, 3-dioxygenase and tryptophan-2, 3-dioxygenase in liver diseases","volume":"9","author":"Zhou","year":"","journal-title":"Ann. Transl. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.joim.2025.03.002","article-title":"Therapeutic role of Prunella vulgaris L. polysaccharides in non-alcoholic steatohepatitis and gut dysbiosis","volume":"23","author":"Zhu","year":"2025","journal-title":"J. Integr. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1655026\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T08:00:46Z","timestamp":1758528046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1655026\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":40,"alternative-id":["10.3389\/fphar.2025.1655026"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1655026","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"article-number":"1655026"}}